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The myeloid translocation gene (MTG) homologue Nervy associates with PlexinA on the plasma
membrane, where it functions as an A-kinase anchoring protein (AKAP) to modulate plexin-medi-
ated semaphorin signaling in Drosophila. Mammalian MTG16b is an AKAP found in immune cells
where plexin-mediated semaphorin signaling regulates immune responses. This study provides
the ﬁrst evidence that MTG16b is a dual AKAP capable of binding plexins. These interactions are
selective (PlexinA1 and A3 bind MTG, while PlexinB1 does not) and can be regulated by PKA-phos-
phorylation. Collectively, these data suggest a possible mechanism for the targeting and integration
of adenosine 30,50-cyclic monophosphate (cAMP) and semaphorin signaling in immune cells.
Structured summary:
MINT-7556975: PlexinA3 (uniprotkb:P51805) physically interacts (MI:0915) with MTG 16b (uni-
protkb:O75081) by anti tag coimmunoprecipitation (MI:0007)
MINT-7557008: RI alpha (uniprotkb:Q9DBC7) physically interacts (MI:0915) with MTG 16b (uni-
protkb:O75081) by anti bait coimmunoprecipitation (MI:0006)
MINT-7556989: MTG 16b (uniprotkb:O75081) physically interacts (MI:0915) with PlexinA3 (uni-
protkb:P51805) by pull down (MI:0096)
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Agents that activate the adenosine 30,50-cyclic monophosphate
(cAMP)-dependent second messenger pathway are potent inhibi-
tors of T-cell activation [1,2]. While numerous reports document
the effectiveness of cAMP as an anti-inﬂammatory agent, the
molecular mechanisms producing these effects are still under
investigation. This lack of knowledge has thwarted progress
toward clinical application of therapies that target cAMP. A-kinase
anchoring proteins (AKAPs) are deﬁned by their ability to bind one
or more of the regulatory subunits (type I: RIa and RIb and type II:
RIIa and RIIb) of cAMP-dependent protein kinase A (PKA). These
subunits interact with an amphipathic helix domain on the AKAP.lf of the Federation of European Bi
cAMP, adenosine 30 ,50-cyclic
glutathione S-transferase; IB,
id translocation gene; PKA,
t of type I PKA; RII, regulatory
edical Center, Mail Code R&D
97239, USA. Fax: +1 503 721AKAPs target the action of PKA signaling by acting as scaffolding
proteins, spatially restricting function by simultaneously binding
related signal transduction enzymes [3,4]. We have identiﬁed se-
ven different AKAPs in T lymphocytes and dendritic cells, including
the discovery of a novel AKAP, myeloid translocation gene (MTG)
[4,5]. MTG was originally identiﬁed as a fusion protein with AML
in patients with acute myeloid leukemia and has been detected
in the nucleus, cytoplasm and Golgi [6]. MTG acts as an regulatory
subunit of type II PKA (RII) binding AKAP and is thus a potential
adaptor protein for cAMP signaling in immune response [4,7].
However, a growing body of evidence suggests that the type I
PKA isoforms may play a greater role in regulating the immune re-
sponse; mice lacking RIIa have normal immune responses to
cAMP, type I regulatory subunits co-localize with the TCR during
T-cell activation [8], and activation of PKA type I alpha alone is suf-
ﬁcient for cAMP-dependent immunosuppression [9]. Thus, it
would be interesting to determine whether MTG is a dual AKAP.
Controlling the concentration of cAMP and the activity of PKA is
crucial for directing an axon to its proper target [10]. Insight into
how cAMP dictates axonal steering responses has been gained
from the discovery that Nervy, a Drosophila AKAP with signiﬁcant
homology to MTG, couples plexin to PKA to modulate semaphorinochemical Societies.
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associates with PlexinA on the plasma membrane. Nervy functions
as an AKAP and modulates intracellular signaling initiated by the
interaction of semaphorins and plexins [11]. This ﬁnding suggests
a mechanism for the integration of diverse signaling inputs to the
axonal growth cone [11,12].
The immune and nervous systems are similar in many re-
spects. Both are highly networked systems that interact using
shared molecules such as chemical mediators and cytokines
[13]. T-cells and antigen presenting cells (APCs) form a unique
cellular architecture at their contact zone (the immunological
synapse) that is structurally similar to the neurological synapse
[14]. Several semaphorins have been detected in cells of the im-
mune system and have been shown to be key regulatory mole-
cules controlling the immune response, reviewed in [13,15–17].
The plexin and neurophilin families of semaphorin receptor pro-
teins are also expressed by a variety of immune cells and are in-
volved in semaphorin signaling in the immune system [16,18–
22].
In this study, we investigate whether mammalian proteins
MTG16b and plexins can interact. Results indicate that MTG binds
selectively to plexins, and that this binding can be regulated by
PKA-phosphorylation. Additionally, we determine that MTG is a
dual AKAP, capable of binding both regulatory subunit of type I
PKA (RI) and RII. Taken together, these data indicate that MTG16b
has the potential to scaffold cAMP and semaphorin signaling in im-
mune cells.2. Materials and methods
2.1. Vector constructs
Preparation of MTG16b constructs is described previously
[4,23]. Constructs expressing full-length human PlexinA3-pcDNA,
PlexinB1-pcDNA, and human/mouse chimera PlexinA1-pcDNA
(all VSV-G tagged) were kindly provided by Dr. Luce Tamagnone.
For bacterial expression, restriction enzyme digestion was used
to obtain just the cytoplasmic domain of each plexin: XhoI for Plex-
inA1, EcoRI and NcoI for PlexinA3 and EcoRI for PlexinB1. Frag-
ments were ligated into pET30 (S-protein-tagged) or pGEX-5X
[glutathione S-transferase (GST)-tagged]. For PlexinA3 cloning into
pGEX-5X, primers were designed to add BamHI and NotI restric-
tion sites, respectively: forward 50-CGCGGATCCATGCCATGGTGG
CCCTGCAGAGC-30 and reverse 50-ATAAGAATGCGGCCGCCCTCCTCA
CCGATTCCACCAC-30. Due to poor protein expression using Plexi-
nB1-pcDNA to transfect COS7 cells, PlexinB1 was also expressed
in pEGFP (cut from pcDNA construct as above).
2.2. Transformation, expression and pulldown assays
Methods for transformation, bacterial protein induction and
expression, and pulldown assays are described previously [24].
2.3. Transfection and immunoprecipitation (IP) and immunoblot (IB)
Transfection was performed using Lipofectamine 2000 (Invit-
rogen, Carlsbad, CA) as described previously [24], using 2.5 lg
of MTG-pcDNA (myc-his tagged) and 5 lg of plexin-pcDNA
(VSV-G tagged). Immunoprecipitation and immunoblot methods
are described in [24], with modiﬁcations. Brieﬂy, a glycerol lysis
buffer was used (20 mM Tris–HCl pH 7, 4, 5 mM EDTA, 150 mM
NaCl, 10% glycerol, 1% Triton-X 100, and protease inhibitors as
in [24]. IP antibodies were: rabbit polyclonal anti-VSV-G (8 lg;
Sigma–Aldrich, St. Louis, MO), mouse monoclonal anti-myc
(10 lg; Santa Cruz Biotechnology, Santa Cruz, CA; used to IPMTG rather than PlexinB1-GFP in co-IP experiments due to the
myc antibody0s superior performance in IP assays compared to
the green ﬂuorescent protein (GFP) antibody), or mouse monoclo-
nal anti-RI (4 lg, BD Biosciences, San Jose, CA). Isotype appropri-
ate IgG (all BD Biosciences) in amounts equal to IP antibody was
used as a negative control in each IP. IB antibodies were VSV-G
(1:2000), myc (1:500), RI (1:300), and rabbit polyclonal anti-
GFP (1:250; Clontech, Mountain View, CA). Genscript (Piscataway,
NJ) One Hour IP Western Kit was used according to manufac-
turer0s instructions for RI western blots to minimize interference
from IP/IgG cross reaction with the IB antibody.
2.4. Phosphorylation
Phosphorylation for pulldown experiments is described in [3].3. Results/discussion
Unless otherwise speciﬁed, proteins in this section are recombi-
nant and tagged to facilitate IPs and IBs. Appropriate controls are
included to ensure that binding is speciﬁc to the protein and not
the tags. See ﬁgure legends for detail.
3.1. MTG interacts with plexins
To determine whether MTG interacts with plexins, two types
of binding assays were performed. Co-immunoprecipitation
experiments using co-transfected COS7 cells revealed that full-
length (FL) MTG interacts with plexins A1 and A3, but not Plexi-
nB1 (Fig. 1A, compare lane 3 in upper panels). To conﬁrm the re-
sults of IP experiments using a second method, to delineate the
binding domains involved, and to examine the effects of phos-
phorylation on binding, MTG16b (FL and fragments: amino acids
200–700, 700–1510, and 1510–2000) was bacterially expressed.
Due to the fact that MTG is not a membrane or extracellularly ex-
pressed protein, we hypothesized that it would interact with the
highly conserved cytoplasmic domain of plexins [4]. As such, we
subcloned and expressed just the cytoplasmic domains (C1 and
C2) of plexins A1, A3 and B1. Consistent with co-immunoprecip-
itation assays, the cytoplasmic domains plexins A1 and A3 bound
to FL MTG16b, while PlexinB1 did not (Fig. 1B, compare lane 3 in
upper panels). Interestingly, in fragment pulldowns, plexins A1
and A3 bound well to FL MTG, but they both bound only weakly
and inconsistently to the MTG fragments (primarily binding to
the 200–700 and 700–1510 fragments, data not shown). This
may indicate that proper folding of the intact FL MTG protein is
required for optimal binding of plexins.
3.2. MTG is a dual AKAP
We used co-IP and pulldown assasy to determine whether
MTG interacts with RI. Co-IP experiments using MTG transfected
COS7 cells revealed that MTG interacts with endogenously ex-
pressed RI (Fig. 2A). To conﬁrm a direct interaction, puriﬁed RIa
and MTG were used in pulldown assays. Consistent with co-
immunoprecipitation assays, RIa interacts with FL MTG
(Fig. 2B). Together with our previous studies that demonstrate
RII-MTG interactions [4], these data indicate that MTG is a dual
AKAP. This result is supported by recently published sequence
analyses suggesting that in addition to the well-characterized
RII-binding amphipathic helix domain, dual AKAPs contain a
PKA binding region called the RI Speciﬁer Region (RISR) [25]. Se-
quence alignment with the dual AKAPs presented in the Jarnaess
study indicate that MTG16b contains the RISR motif (Supplemen-
tary data).
Fig. 1. MTG interacts with PlexinA1 and PlexinA3, but not PlexinB1. (A) COS7
cells were co-transfected with full-length MTG-pcDNA(myc-His) and PlexinA1-
pcDNA, PlexinA3-pcDNA (both VSV-G tagged), or PlexinB1-pEGFP. Lane 1 in all
panels is a lysate control for transfection. In the PlexinA1 and PlexinA3 panels,
immunoprecipitations (IP) were performed with negative control IgG (lane 2) or
VSV-G polyclonal antibody (lane 3). After SDS-PAGE and transfer, membranes
were cut in half and immunoblotted (IB) with anti-VSV-G antibody to conﬁrm IP
(top panel), or anti-myc antibody (bottom panel), demonstrating that MTG co-IP
with plexins A1 and A3. In the PlexinB1 panel, IPs were performed with negative
control IgG (lane 2) or anti-myc monoclonal antibody (lane 3). Anti-myc antibody
IB was performed to conﬁrm IP, and polyclonal anti-GFP antibody IB was
performed, demonstrating that MTG does not co-IP with PlexinB1. (B) Pulldown
assays using bacterially expressed proteins and glutathione sepharose (GST)
beads. Lane 1 in each panel is the plexin-S tagged protein. Plexin-S tagged
protein lysates were incubated with GST beads alone (data not shown), GST
beads bound to GST lysates (lane 2), or MTG-GST lysates (lane 3). Western
analysis was used to detect binding of plexins (upper blot in each panel) to GST
(lower blot in each panel). In (A) and (B) the results are representative blots of
three independent experiments.
Fig. 2. MTG interacts with RI. (A) COS7 cells were transfected with full-length MTG-
pcDNA(myc-His). Lane 1 in both panels is a lysate control to demonstrate size and
conﬁrm transfection. IPs were performed with negative control IgG (lane 2) or RI
monoclonal antibody (lane 3). After SDS-PAGE and transfer, membranes were cut in
half and immunoblotted (IB) with anti-RI antibody to conﬁrm IP (top panel), or anti-
myc antibody (bottom panel) to demonstrate that MTG co-IPs with RI. Both IBs used
Genscript’s (Piscataway, NJ) one-step IP Western blot kit. Since different antibodies
are used, resulting bands should not be considered quantitative measures of
protein. (B) Pulldown assays using S-protein beads. Lane 1 is RIa protein bacterial
lysate compared to pulldown lanes 2 and 3. Bacterially expressed, afﬁnity-puriﬁed
RIa was incubated with S-protein beads alone (data not shown), S-protein beads
bound to S-protein bacterial lysates (lane 2), or MTG-S protein bacterial lysates
(lane 3). Western analyses with anti-RIa monoclonal antibody were used to detect
RI binding. In (A) and (B) the results are representative blots of three independent
experiments.
Fig. 3. MTG can form a complex with plexin and RIa. In modiﬁed pulldown assays,
PlexinA3-GST was immobilized on GST beads and incubated with either negative
control S-protein (lane 1) or MTG-S protein (lane 2). Both sets of beads were then
washed and incubated with bacterially expressed, cAMP afﬁnity-puriﬁed RIa (lanes
1 and 2). The samples were separated by SDS–PAGE, transferred to Immobilon PVDF
membranes, and western blots were performed with anti-RIamonoclonal antibody
and goat anti-mouse-HRP-conjugated secondary antibody in order to detect
binding of RI (lower blot). Anti-GST-HRP and anti-S protein-HRP western blots
were also performed in order to conﬁrm loading of PlexinA3 (upper blot) and MTG
(middle blot), respectively. These results are representative blots of three indepen-
dent experiments.
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In functioning as scaffolding proteins that target PKA-phosphor-
ylation, AKAPs will often simultaneously bind the R subunits of
PKA and PKA substrate(s) [23,24]. To illustrate that MTG binds
RIa and plexins concurrently, forming a signaling complex, we per-
formed pulldown assays. Results indicate that MTG is capable of
and necessary for forming a complex with plexins and RIa
(Fig. 3, lane 2) as RIa and PlexinA3 do not interact directly
(Fig. 3, lane 1).3.4. Phosphorylation affects MTG interactions with RI and plexins
Phosphorylation is a key event in many signaling pathways, of-
ten manifesting its effects by altering binding afﬁnities. Recent
studies have demonstrated regulation of AKAP protein interactions
via PKA-phosphorylation of the AKAPs. Furthermore PlexinA, the
drosophila plexin that interacts with MTG family member Nervy,
may be a target for PKA-phosphorylation [3,12]. In addition, tyro-
sine phosphorylation of plexins is important in semaphorin signal-
ing [26]. As such, we performed studies to test the hypothesis that
PKA-phosphorylation affects plexin/MTG/RI interactions. To begin,
Fig. 4. PKA phosphorylation affects MTG interactions with plexins and RI. (A) MTG-
S protein was immobilized on S-protein beads and either left unphosphorylated
(bar 1 and lane 1 in each blot) or phosphorylated by the catalytic subunit of PKA
(bar 2 and lane 2 in each blot). GST-PlexinA1 (left), GST-PlexinA3 (middle), or
puriﬁed RIa (right) lysates were then incubated with the bead-bound MTG. Samples
were electrophoresed, transferred and anti-GST-HRP western blots were performed
to detect binding of the plexins or RIa to MTG. Phosphorylation of MTG by PKA
resulted in a signiﬁcant increase in binding to all proteins tested (PlexinA1 P = 0.04,
PlexinA3 P = 0.02, and RIa P = 0.02 by t-test;  denote signiﬁcance). (B) PlexinA1-
GST (left) or PlexinA3-GST (right) is immobilized on GST beads and either left
unphosphorylated (bar 1 and lane 1 in each blot) or phosphorylated by the catalytic
subunit of PKA (bar 2 and lane 2 in each blot). MTG-S protein lysate was then
incubated with the bead-bound plexins. Western analysis detects binding of the
MTG to plexins. Phosphorylation of PlexinA3 by PKA resulted in a signiﬁcant
increase in binding to MTG (P = 0.01 by t-test,  denotes signiﬁcance), while
phosphorylation of PlexinA1 did not affect its interaction with MTG. The blots in A
and B are each one representative of three separate experiments in which equal
loading was determined by coomassie staining and western blot (anti-S protein-
HRP, A, anti-GST-HRP, B). PKA-phosphorylation of proteins was conﬁrmed using the
anti-phospho-serine PKA substrate antibody. Densitometric analyses were per-
formed using NIH Image software. Error bars are ± S.E.M.
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phorylation on MTG, which are S536 and S411 (see Supplementary
data).
Using FL MTG, puriﬁed RIa, and the cytosolic domains of Plex-
inA1 or PlexinA3 (see above), we performed pulldown assays to
determine whether PKA-phosphorylation of either MTG or plexins
alters interactions (RIa is constitutively phosphorylated in vivo).First, MTG was immobilized on beads and PKA-phosphorylated,
plexins or puriﬁed RIa were added. Binding was compared to
unphosphorylated MTG. Results indicate that PKA-phosphoryla-
tion of MTG signiﬁcantly increases its interaction with PlexinA1,
PlexinA3, and RIa (Fig. 4A). In reverse pulldowns, plexins were
immobilized and PKA phosphorylated as above, then MTG was
added. Results indicate that PKA-phosphorylation of PlexinA3 in-
creases its interaction with MTG (Fig. 4B, right), while PKA-phos-
phorylation of PlexinA1 has no effect on its interaction with MTG
(Fig. 4B, left).
4. Conclusion
In summary, this study provides the ﬁrst evidence that MTG16b
is a dual AKAP capable of binding plexins. Additionally, we report
that these interactions are speciﬁc (PlexinA1 and A3 are bound,
while PlexinB1 is not) and can be regulated by PKA-phosphoryla-
tion. Collectively, these data suggest a possible mechanism for
the targeting and integration of cAMP and semaphorin signaling
in immune cells.
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